It wasn't an easy journey but I couldn't be more grateful.
A million thanks to all the friends and family who made it possible! and to @USJLiban @UWorldMedical @ambossmed
Excited for what the future holds!
@StoriesImg @IMG_Advocate @ImgJourney
Eddy Saad
631 posts
IM PGY-1 @BIDMC_IM @harvardmed | Postdoctoral GU Oncology Research Fellow @DanaFarber | MD '22 MSc '21 @USJLiban
Boston, MA
Joined August 2021
- As promised, here is my write-up on reddit: bit.ly/3qv2XLK In case you have any other questions, feel free to message me. Good luck!It wasn't an easy journey but I couldn't be more grateful. A million thanks to all the friends and family who made it possible! and to @USJLiban @UWorldMedical @ambossmed Excited for what the future holds! @StoriesImg @IMG_Advocate @ImgJourneyreddit.comFrom the Step2 community on RedditExplore this post and more from the Step2 community
- Hello #MedTwitter! I’m Eddy Saad, a @USJLiban graduate 🇱🇧 and currently a postdoc fellow studying kidney cancer and immunotherapy 🤓 @DanaFarber @harvardmed Incredibly grateful for the opportunity to be applying for the #InternalMedicine #Match2025 ! AAMC ID: 16349429 #IMG
- Incredibly honored and thrilled to have matched at my top choice @BIDMC_IM! Beyond grateful to my amazing mentors, friends, and family who supported me every step of the way @DrChoueiri @VanAllenLab @BraunMDPhD @SashaGusevPosts @maxinesun
- Hard to describe how big of a moment that was! Congrats Dr @ReneeSaliby for a brilliant @ASCO presentation! You make us all proud! And kudos to the whole team behind this work @MarcMachaalani @CarolinaAlvesC5. It truly takes a village!
- Thanks guys for all your messages. Incredibly heartwarming! I will do a write-up soon, I promise. In the mean time, you can check out my step 1 write-up on reddit. bit.ly/3BsUZJp Never stop believing in yourself and have faith!
- Excited to share our work @OncJournal co-led by @ggebraelmd and mentored by @DrChoueiri @DrDanielHeng While smoking cessation is crucial 🚭, smoking status does not independently affect outcomes in pts w/ #mRCC treated w/ 1L ICI @OncoAlert @urotoday tinyurl.com/mv44nycci
- It was an honor to deliver the student speech at yesterday's graduation ceremony 🎓 @USJLiban It was inspired by so many amazing people I had the pleasure of sharing this journey with and for whom I will be forever grateful ❤
- The one and only @DrChoueiri presenting results from #TiNivo2 #ESMO2024 @myESMO Paper out @TheLancet : thelancet.com/journals/lance… Another study after #CONTACT03 showing no benefit of rechallenging with anti-PD-1/PD-L1 after progression on ICI in #mRCC @OncoAlert @DanaFarberNews
- 📚Check out our review on novel immune targets for renal cell carcinoma #RCC ! Link below 👇 Huge thanks to @ReneeSaliby @Chrislabaki1 @ZiadBakouny @BraunMDPhD @VincentWenxinXu @srviswanathan @DrChoueiri for their invaluable mentorship and support! authors.elsevier.com/a/1hKJe3AL9d2v…
- Landmark moment in the history of #RCC @DrChoueiri revealing the 1st ever OS benefit for adjuvant treatment in RCC with pembro 38% decrease in the risk of death. Huge! #GU24 @OncoAlert
- Thank you @IMG_Oncologists for this inspiring discussion! What an amazing way to kick off my 1st #ASCO23 A reminder of the struggles and achievements of #IMGs (lessons learned by @teekayowo )
- Grateful for the unwavering support of my mentors @DrChoueiri and @VanAllenLab It was a pleasure to present part of our work with @Chrislabaki1 @ZiadBakouny @BenMironMD @MattZibelman @ERPlimackMD Check out our poster # 459 at @ASCO #GU24 on Saturday!Brilliant work by @eddy_saad on multi-omic characterization of acquired resistance to ICI in mRCC! @VanAllenLab @DanaFarber_GU @OncLive























